These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24880005)

  • 21. A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.
    Matsuzaki Y; Mizuta K; Aoki Y; Suto A; Abiko C; Sanjoh K; Sugawara K; Takashita E; Itagaki T; Katsushima Y; Ujike M; Obuchi M; Odagiri T; Tashiro M
    Virol J; 2010 Mar; 7():53. PubMed ID: 20202225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor".
    Liu T; Liu M; Chen F; Chen F; Tian Y; Huang Q; Liu S; Yang J
    Mol Pharm; 2018 Sep; 15(9):4110-4120. PubMed ID: 30102858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.
    Duwe SC; Wedde M; Birkner P; Schweiger B
    Antiviral Res; 2011 Jan; 89(1):115-8. PubMed ID: 21070812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arylazolyl(azinyl)thioacetanilide. Part 9: Synthesis and biological investigation of thiazolylthioacetamides derivatives as a novel class of potential antiviral agents.
    Zhan P; Wang L; Liu H; Chen X; Li X; Jiang X; Zhang Q; Liu X; Pannecouque C; Naesens L; De Clercq E; Liu A; Du G
    Arch Pharm Res; 2012 Jun; 35(6):975-86. PubMed ID: 22870806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.
    Chen X; Si L; Liu D; Proksch P; Zhang L; Zhou D; Lin W
    Eur J Med Chem; 2015 Mar; 93():182-95. PubMed ID: 25681711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral activity of a synthesized shikonin ester against influenza A (H1N1) virus and insights into its mechanism.
    Zhang Y; Han H; Qiu H; Lin H; Yu L; Zhu W; Qi J; Yang R; Pang Y; Wang X; Lu G; Yang Y
    Biomed Pharmacother; 2017 Sep; 93():636-645. PubMed ID: 28688289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.
    Matusevich OV; Egorov VV; Gluzdikov IA; Titov MI; Zarubaev VV; Shtro AA; Slita AV; Dukov MI; Shurygina AP; Smirnova TD; Kudryavtsev IV; Vasin AV; Kiselev OI
    Antiviral Res; 2015 Jan; 113():4-10. PubMed ID: 25446335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
    Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
    Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oseltamivir inhibits both viral entry and release but enhances apoptosis of cells infected with influenza A H1N1.
    Gao R; Du N; Liu D; Li Z; Zhu Y; Shu Y
    Biochem Biophys Res Commun; 2013 Feb; 431(4):788-95. PubMed ID: 23333739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antiviral effects of Peganum harmala seed extract and its total alkaloids against Influenza virus.
    Moradi MT; Karimi A; Rafieian-Kopaei M; Fotouhi F
    Microb Pathog; 2017 Sep; 110():42-49. PubMed ID: 28629724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, and in vitro biological evaluation of novel 6-methyl-7-substituted-7-deaza purine nucleoside analogs as anti-influenza A agents.
    Lin C; Sun C; Liu X; Zhou Y; Hussain M; Wan J; Li M; Li X; Jin R; Tu Z; Zhang J
    Antiviral Res; 2016 May; 129():13-20. PubMed ID: 26802557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro.
    Haasbach E; Hartmayer C; Planz O
    Antiviral Res; 2013 May; 98(2):319-24. PubMed ID: 23523553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza virus resistance to neuraminidase inhibitors.
    Samson M; Pizzorno A; Abed Y; Boivin G
    Antiviral Res; 2013 May; 98(2):174-85. PubMed ID: 23523943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.
    Dharan NJ; Beekmann SE; Fiore A; Finelli L; Uyeki TM; Polgreen PM; Fry AM
    Antiviral Res; 2010 Nov; 88(2):182-6. PubMed ID: 20739002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-influenza virus activity of Myrica rubra leaf ethanol extract evaluated using Madino-Darby canine kidney (MDCK) cells.
    Mochida K
    Biosci Biotechnol Biochem; 2008 Nov; 72(11):3018-20. PubMed ID: 18997411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel influenza A(H1N1) 2009 in vitro reassortant viruses with oseltamivir resistance.
    Ottmann M; Duchamp MB; Casalegno JS; Frobert E; Moulès V; Ferraris O; Valette M; Escuret V; Lina B
    Antivir Ther; 2010; 15(5):721-6. PubMed ID: 20710053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral.
    Hu Y; Zhang J; Musharrafieh R; Hau R; Ma C; Wang J
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A.
    Schade D; Kotthaus J; Riebling L; Kotthaus J; Müller-Fielitz H; Raasch W; Koch O; Seidel N; Schmidtke M; Clement B
    J Med Chem; 2014 Feb; 57(3):759-69. PubMed ID: 24422530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
    Hurt AC; Lowther S; Middleton D; Barr IG
    Antiviral Res; 2010 Sep; 87(3):361-6. PubMed ID: 20603155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein.
    Cheng H; Wan J; Lin MI; Liu Y; Lu X; Liu J; Xu Y; Chen J; Tu Z; Cheng YS; Ding K
    J Med Chem; 2012 Mar; 55(5):2144-53. PubMed ID: 22332894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.